References of "Hubert, Philippe"
     in
Bookmark and Share    
Full Text
See detailA Bayesian Design Space for analytical methods based on multivariate models and predictions
Lebrun, Pierre ULg; Boulanger, Bruno ULg; Debrus, Benjamin ULg et al

in Journal of Biopharmaceutical Statistics (in press)

The International Conference for Harmonization (ICH) has released regulatory guidelines for Pharmaceutical Development. In the document ICH Q8, The Design Space of a process is presented as the set of ... [more ▼]

The International Conference for Harmonization (ICH) has released regulatory guidelines for Pharmaceutical Development. In the document ICH Q8, The Design Space of a process is presented as the set of factor settings providing satisfactory results. However, ICH Q8 does not propose any practical methodology to define, derive and compute Design Space. In parallel, in the last decades, it has been observed that the diversity and the quality of analytical methods have evolved exponentially allowing substantial gains in selectivity and sensitivity. However, there is still a lack for a rationale towards the development of robust separation methods in a systematic way. Applying ICH Q8 to analytical methods provides a methodology for predicting a region of the space of factors in which results will be reliable. Combining design of experiments and Bayesian standard multivariate regression, an identified form of the predictive distribution of a new response vector has been identified and used, under non-informative as well as informative prior distributions of the parameters. From the responses and their predictive distribution, various critical quality attributes can be easily derived. This Bayesian framework was then extended to the multi-criteria setting to estimate the predictive probability that several critical quality attributes will be jointly achieved in the future use of an analytical method. An example based on a high-performance liquid chromatography (HPLC) method is given. For this example, a constrained sampling scheme was applied to ensure the modeled responses have desirable properties. [less ▲]

Detailed reference viewed: 89 (27 ULg)
Full Text
See detailChemical imaging of small molecules from simple to complex matrices: Quantitative approches based on Surface Enhanced Raman scattering
De Bleye, Charlotte ULg; Sacre, Pierre-Yves ULg; Chavez, Pierre-François ULg et al

Conference (2013, July)

Surface Enhanced Raman scattering (SERS) allows to dramatically exalt the Raman diffusion of molecules absorbed or very closed to rough metallic surfaces while keeping their structural information. SERS ... [more ▼]

Surface Enhanced Raman scattering (SERS) allows to dramatically exalt the Raman diffusion of molecules absorbed or very closed to rough metallic surfaces while keeping their structural information. SERS chemical imaging, presenting a high specificity and sensibility, allows acquiring a visual representation of samples combining spectral and spatial measurements. This technique could become a powerful tool in pharmaceutical and biological analysis enabling to identify and quantify molecules thanks to chemometric evaluation while looking at their distribution or their interactions. In this context, SERS chemical imaging is investigated in detection or quantitative determination of molecules in pharmaceutical and biological matrices. The feasibility of making quantitative measurements using SERS is evaluated on small target molecules models such as 4-aminophenol and lactate. Firstly, a SERS method to quantify 4-aminophenol which is the primary impurity of acetaminophen coming from its degradation during the storage or from its synthesis was developed on a real pharmaceutical formulation. The standard addition method was selected as calibration method in order to take into account the matrix effect coming from the different components of the latter. Despite the well-known stability and repeatability problems of SERS, the method was thoroughly validated by means of accuracy profiles as decision tool. Moreover, this validation methodology allowed to define a first estimation of the real analytical performance of the technique. Secondly, the detection of lactate, which is a critical metabolite implicated in several metabolic disorders, was successfully tested in the physiological concentration in a simple matrix. Preliminary results for the determination of this metabolic biomarker were also very promising allowing to consider more complex matrices. Based on these results, SERS chemical imaging was implemented to detect 4-aminophenol in a pharmaceutical tablet formerly pulverised by a SERS substrate. Through this imaging technique, it was not only possible to detect the presence of the impurity at the limit of specification of 0.1% (w/w) but it was also possible to differentiate tablets comprising different concentrations of the latter. These promising results represent the first step towards quantitative measurements using SERS chemical imaging. [less ▲]

Detailed reference viewed: 40 (16 ULg)
Full Text
See detailInnovative Methodology for the Definition of Design Spaces of Chromatographic Methods
Rozet, Eric ULg; Debrus, B; Lebrun, Pierre ULg et al

Conference (2013, June 06)

As defined by ICH [1] and FDA, Quality by Design (QbD) stands for “a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process ... [more ▼]

As defined by ICH [1] and FDA, Quality by Design (QbD) stands for “a systematic approach to development that begins with predefined objectives and emphasizes product and process understanding and process control, based on sound science and quality risk management”. A risk–based QbD–compliant approach is proposed for the robust development of analytical methods. This methodology based on Design of Experiments (DoE) to study the experimental domain models the retention times at the beginning, the apex and the end of each peak corresponding to the compounds of a mixture and uses the separation criterion (S) rather than the resolution (RS) as a Critical Quality Attribute. Stepwise multiple linear regressions are used to create the models. The estimated error is propagated from the modelled responses to the separation criterion (S) using Monte Carlo simulations in order to estimate the predictive distribution of the separation criterion (S) over the whole experimental domain. This allows finding ranges of operating conditions that will guarantee a satisfactory quality of the method in its future use. These ranges define the Design Space (DS) of the method. In chromatographic terms, the chromatograms processed at operating conditions within the DS will assuredly show high quality, with well separated peaks and short run time, for instance. This Design Space can thus be defined as the subspace, necessarily encompassed in the experimental domain (i.e. the knowledge space), within which the probability for the criterion to be higher than an advisedly selected threshold is higher than a minimum quality level. Precisely, the DS is defined as “the multidimensional combination and interaction of input variables (e.g., material attributes) and process parameters that have been demonstrated to provide assurance of quality” [1]. Therefore, this DS defines a region of operating conditions that provide prediction of assurance of quality rather than only quality as obtained with traditional mean response surface optimisation strategies. For instance, in the liquid chromatography there is a great difference in e.g. predicting a resolution (RS) higher than 1.5 vs. predicting that the probability for RS to be higher than 1.5 (i.e. P(RS> 1.5)) is high. The presentation of this global methodology will be illustrated for the robust optimisation and DS definition of several liquid chromatographic methods dedicated to the separation of different mixtures: pharmaceutical formulations, API and impurities/degradation products, plant extracts, separation of enantiomers, … [less ▲]

Detailed reference viewed: 6 (5 ULg)
Full Text
See detailA BAYESIAN PROBABILITY CRITERION TO ASSESS ANALYTICAL RESULTS RELIABILITY
Rozet, Eric ULg; Lebrun, Pierre ULg; Boulanger, B et al

Conference (2013, May 21)

In pharmaceutical and biomedical industries, quantitative analytical methods such as HPLC play a key role. Indeed, the analytical results obtained from them are used to make crucial decisions such as the ... [more ▼]

In pharmaceutical and biomedical industries, quantitative analytical methods such as HPLC play a key role. Indeed, the analytical results obtained from them are used to make crucial decisions such as the release of batches of drugs, the evaluation of safety and efficacy of new drug candidates or the monitoring of patients health. Prior to their routine use, analytical methods are submitted to a stringent validation study [1] where they have to demonstrate that they are fit for their final purpose, i.e. providing accurate results: where is the analytical result, is the theoretical unknown true concentration of analyte in the sample analyzed and a regulatory acceptance limit. Typically this demonstration is made by either providing point estimates of systematic error (bias) and random error (variance) or sometimes by providing interval estimates of these statistical parameters at several well defined concentration levels of the target analyte [2]. They are then compared to maximum acceptable levels. More recently, tolerance intervals approaches have been proposed that are evaluated in a similar way at these key concentration levels [3]. However none of these decision approaches allow knowing the probability to obtain accurate results over the whole concentration range of interest: is a vector of parameters and Pmin is a minimum reliability probability. Frequentist approximations have been proposed to estimate this probability but only at the concentration levels experimentally tested [4,5]. In this work, a linear hierarchical Bayesian approach is proposed. It takes into account the potential random characteristic of the slope and intercept observed from one analytical run to the other, but it also integrates the possible covariance between the parameters. Additionally, heteroscedasticity of the residual variance over the concentration range investigated is taken into account. A situation regularly observed in practice. Finally a reliability profile for the whole concentration range studied is obtained using MCMC sampling. This profile provides the probability (Prel) to obtain accurate results over the full concentration range investigated. This profile is then compared to a minimum reliability probability (Pmin) that will define the valid concentration range of the analytical method. The usefulness of this approach is illustrated through the validation of a bioanalytical method and also compared with one concentration level at a time frequentist approaches [4,5]. [1] International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for Human Use Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva, 2005. [2] A. Bouabidi and al., J. Chromatogr. A, 1217 (2010) 3180. [3] Ph. Hubert and al., J. Pharm. Biomed. Anal., 36 (2004) 579. [4] W. Dewé and al., Chemometr. Intell. Lab. Syst. 85 (2007) 262. [5] B. Govaerts and al., Qual. Reliab. Engng. Int. 24 (2008) 667. [less ▲]

Detailed reference viewed: 5 (1 ULg)
Full Text
See detailValidation methodologies of near infrared spectroscopy methods in pharmaceutical applications
Chavez, Pierre-François ULg; De Bleye, Charlotte ULg; Sacre, Pierre-Yves ULg et al

in European Pharmaceutical Review (2013), 18(1), 3-6

As any analytical methods, a mandatory step at the end of the development of a near infrared spectroscopy (NIRS) method is the validation. This step enables to give enough guarantees that each future ... [more ▼]

As any analytical methods, a mandatory step at the end of the development of a near infrared spectroscopy (NIRS) method is the validation. This step enables to give enough guarantees that each future results coming from the application of the method in routine will be closed enough to the true value. However, from the literature, a minority of NIRS methods are thoroughly validated despite of the guidelines published by different group and regulatory authorities to help analyst to adequately decide if his method can be considered as valid. In this context, the aim of this review is to offer a critical overview of the different validation methodologies applied to assess the validity of quantitative methods using near infrared spectroscopy used in the field of pharmacy. [less ▲]

Detailed reference viewed: 59 (8 ULg)
Full Text
See detailMethodology for the Validation of Analytical Methods involved in Uniformity of Dosage Units tests
Rozet, Eric ULg; Ziemons, Eric ULg; Marini Djang'Eing'A, Roland ULg et al

in Analytica Chimica Acta (2013), 760

Validation of analytical methods is required prior to their routine use. In addition, the current implementation of the Quality by Design (QbD) framework in the pharmaceutical industries aims at improving ... [more ▼]

Validation of analytical methods is required prior to their routine use. In addition, the current implementation of the Quality by Design (QbD) framework in the pharmaceutical industries aims at improving the quality of the end products starting from its early design stage. However, no regulatory guideline or none of the published methodologies to assess method validation propose decision methodologies that effectively take into account the final purpose of developed analytical methods. In this work a solution is proposed for the specific case of validating analytical methods involved in the assessment of the Content Uniformity or Uniformity of Dosage Units of a batch of pharmaceutical drug products as proposed in the European or US pharmacopoeias. This methodology uses statistical tolerance intervals as decision tools. Moreover it adequately defines the Analytical Target Profile of analytical methods in order to obtain analytical methods that allow to make correct decisions about Content Uniformity or Uniformity of Dosage Units with high probability. The applicability of the proposed methodology is further illustrated using an HPLC-UV assay as well as a Near Infra-Red Spectrophotometric method. [less ▲]

Detailed reference viewed: 34 (10 ULg)
Full Text
See detailDesign Spaces for Analytical Methods: what, why, how?
Rozet, Eric ULg; Lebrun, Pierre ULg; Debrus, Benjamin ULg et al

in Trends in Analytical Chemistry [=TRAC] (2013), 42

Since the adoption of the ICH Q8 document concerning the development of pharmaceutical processes following a Quality by Design (QbD) approach, there have been many discussions on the opportunity for ... [more ▼]

Since the adoption of the ICH Q8 document concerning the development of pharmaceutical processes following a Quality by Design (QbD) approach, there have been many discussions on the opportunity for analytical method developments to follow a similar approach. A key component of the QbD paradigm is the definition of the Design Space of analytical methods where assurance of quality is provided. Several Design Spaces for analytical methods have been published, stressing the importance of this concept. This paper aims at explaining what is an analytical method Design Space, why it is useful for the robust development and optimization of analytical methods and how to build such a Design Space. A strong emphasis is made by distinguishing the usual mean response surface approach, overlapping mean response surfaces and the desirability function one to other probabilistic approaches as only these last ones correctly define a Design Space. In addition, recent publications assessing the Design Space of analytical methods are reviewed and discussed. [less ▲]

Detailed reference viewed: 368 (20 ULg)
Full Text
See detailImplementation of a Design Space Approach for Enantiomeric Separations in Polar Organic Solvent Chromatography
Nistor, Iolanda; Lebrun, Pierre ULg; Ceccato, Attilio ULg et al

in Journal of Pharmaceutical & Biomedical Analysis (2013), 74

This paper focuses on implementing a Design Space approach and on the critical process parameters (CPPs) to consider when applying the Quality by Design (QbD) concepts outlined in ICH Q8(R2), Q9 and Q10 ... [more ▼]

This paper focuses on implementing a Design Space approach and on the critical process parameters (CPPs) to consider when applying the Quality by Design (QbD) concepts outlined in ICH Q8(R2), Q9 and Q10 to analytical method development and optimization for three chiral compounds developed as modulators of small conductance calcium-activated potassium (SK) channels. In this sense, an HPLC method using a polysaccharide-based stationary phase containing a cellulose tris (4-chloro-3-methylphenylcarbamate) chiral selector in polar organic solvent chromatography mode was considered. The effects of trifluoroacetic acid (TFA) and n-hexane concentration in an acetonitrile (MeCN) mobile phase were investigated under a wide range of column temperatures. Good correlations were found between the observed data obtained after using a central composite design and the expected chromatographic behaviours predicted by applying the design of experiments-design space (DoE-DS) methodology. The critical quality attribute represented here by the separation criterion (Scrit) allowed assessing the quality of the enantioseparation. Baseline separation for the compounds of interest in an analysis time of less than 20 minutes was possible due to the original and powerful tools applied which facilitated an enhanced method comprehension. Finally, the advantage of the DoE-DS approach resides in granting the possibility to concurrently assess robustness and identify the optimal conditions which are compound dependent. [less ▲]

Detailed reference viewed: 53 (22 ULg)
Full Text
See detailIntérêt de la microscopie vibrationnelle dans la recherche de nouvelles formulations pharma-ceutiques à haute valeur ajoutée.
Sacre, Pierre-Yves ULg; Marini Djang'Eing'A, Roland ULg; Ziemons, Eric ULg et al

Report (2012)

La grande majorité des nouvelles molécules actives présente une faible biodisponibilité dans des formulations pharmaceutiques simples contenant principalement un ou plusieurs constituants et l’actif ... [more ▼]

La grande majorité des nouvelles molécules actives présente une faible biodisponibilité dans des formulations pharmaceutiques simples contenant principalement un ou plusieurs constituants et l’actif faiblement soluble dans l’eau. Dès lors, il est primordial d’investir dans la recherche de nouvelles formulations « plus sophistiquées » (formulations de demain) favorisant la solubilité de l’actif. Cependant cette recherche est limitée par celle de nouveaux outils analytiques pointus permettant de les caractériser, d’étudier les interactions au sein des formulations pharmaceutiques, de comprendre les mécanismes liès à leur formation et in fine de contrôler et garantir leur conformité. Par ailleurs, la Technologie Analytique des Procédés (PAT) est un concept développé par l’Administration Américaine des Aliments et des Médicaments (FDA) et soutenu par l’Agence Européenne des Médicaments (EMA). Ce concept qui devient de plus en plus incontournable (au niveau des dossiers d’Autorisation de Mise sur le Marché). La rapidité de mesure et le caractère non destructif de la spectroscopie vibrationnelle dont fait partie la microscopie Raman la rendent particulièrement compatibles avec ce concept. De plus, les techniques vibrationnelles de part l’absence de préparation de l’échantillon et de l’utilisation de solvant organique rencontrent également le concept de Chimie Verte et donc s’incrivent parfaitement dans un contexte de développement durable et respectueux de l’environnement. L’objectif du présent projet est d’explorer les potentialités de la microscopie Raman dans l’étude pointue des matrices complexes afin d’en améliorer les connaissances tant au niveau de leur charactérisation, des intéractions analyte-matrice que des mécanismes liés à leur formation. L’obtention de ces informations nécéssiteront la recherche de nouvelles méthodologies, outils et règles de décision dédicacés aux aspects qualitatifs et plus encore aux aspects quantiftatifs où l’accès à de telles données est très marginal. L’ensemble de cette recherche sera réalisée sur un modèle complexe, une formulation à haute valeur ajoutée issue de l’industrie pharmaceutique. [less ▲]

Detailed reference viewed: 23 (2 ULg)
Full Text
See detailModèles statistiques Bayésiens et méthodologies pour calculer le Design Space (OPTIMAL-DS)
Marini Djang'Eing'A, Roland ULg; Lebrun, Pierre ULg; Hubert, Philippe ULg

Report (2012)

La compréhension des procédés technologiques et industriels dans les secteurs (bio)pharmaceutiques, biotechnologiques, agroalimentaires et environnementaux doit permettre de se conformer aux lignes de ... [more ▼]

La compréhension des procédés technologiques et industriels dans les secteurs (bio)pharmaceutiques, biotechnologiques, agroalimentaires et environnementaux doit permettre de se conformer aux lignes de conduites initiées par la FDA ou d'autres organismes de contrôles. Notamment, le document ICH Q8 introduit les notions de "Process Analytical Technology", de "Quality by Design" et de "Design Space", ayant attraits à la qualité des procédés industriels, des procédés d'analyse ainsi qu'à la qualité des produits finis. Cependant, si les lignes de conduites pour ces exigences sont expliquées, aucune méthodologie pour les atteindre n'est donnée. Or, un nombre considérable de nouvelles entités chimiques sont synthétisées par les laboratoires pharmaceutiques, biotechnologiques ou agroalimentaires. Les producteurs de matières premières et/ou d’excipients (secteur chimique) ont également besoin de disposer rapidement de méthodes analytiques de contrôle qui leur permettront de s’assurer de la qualité de leurs produits. On comprend aisément la nécessité pour ces secteurs de disposer rapidement de résultats fiables puisque les activités de recherches mais aussi des investissements, souvent importants, sont orientés ou stoppés sur base de données chiffrées, produits par les méthodes analytiques. La production de résultats fiables et la démonstration de cette fiabilité sont donc économiquement fondamentales. Ce projet vise la mise au point de stratégies et de modèles génériques de développement automatisé de nouvelles méthodes analytiques séparatives, en se basant sur la modélisation des temps de rétention, la planification expérimentale, et le concept de Design Space. L’objectif connexe est d’appliquer cette méthodologie à l’optimisation de n’importe quel procédé. Le fait de pouvoir disposer d’une méthodologie de mise au point automatique de méthodes analytiques ou de tous procédés analytiques aura un impact significatif. Cette nouvelle technologie permettra de réduire de façon drastique le temps d’optimisation des méthodes et procédés, permettant une production plus efficiente de produits (pharmaceutique, cosmétique, agro-alimentaire ou biotechnologique) répondant aux spécifications du client. [less ▲]

Detailed reference viewed: 27 (0 ULg)
Full Text
See detailAPPLICATION OF AN INNOVATIVE DESIGN SPACE OPTIMIZATION STRATEGY TO THE DEVELOPMENT OF LC METHODS TO COMBAT POTENTIALLY COUNTERFEIT NONSTEROIDAL ANTIINFLAMMATORY DRUGS
Mbinze Kindenge, Jérémie ULg; Lebrun, Pierre ULg; Debrus, Benjamin ULg et al

in Journal of Chromatography. A (2012), 1263

In the context of the battle against counterfeit medicines, an innovative methodology has been used to develop rapid and specific high performance liquid chromatographic methods to detect and determine 18 ... [more ▼]

In the context of the battle against counterfeit medicines, an innovative methodology has been used to develop rapid and specific high performance liquid chromatographic methods to detect and determine 18 non-steroidal anti-inflammatory drugs, 5 pharmaceutical conservatives, paracetamol, chlorzoxazone, caffeine and salicylic acid. These molecules are commonly encountered alone or in combination on the market. Regrettably, a significant proportion of these consumed medicines are counterfeit or substandard, with a strong negative impact in countries of Central Africa. In this context, an innovative design space optimization strategy was successfully applied to the development of LC screening methods allowing the detection of substandard or counterfeit medicines. Using the results of a unique experimental design, the design spaces of 5 potentially relevant HPLC methods have been developed, and transferred to an ultra high performance liquid chromatographic system to evaluate the robustness of the predicted DS while providing rapid methods of analysis. Moreover, one of the methods has been fully validated using the accuracy profile as decision tool, and was then used for the quantitative determination of three active ingredients and one impurity in a common and widely used pharmaceutical formulation. The method was applied to 5 pharmaceuticals sold in the Democratic Republic of Congo. None of these pharmaceuticals was found compliant to the European Medicines Agency specifications [less ▲]

Detailed reference viewed: 129 (14 ULg)
Full Text
See detailInnovative green supercritical fluid chromatography development for the determination of polar compounds
Dispas, Amandine ULg; Lebrun, Pierre ULg; Sassiat, Patrick et al

in Journal of Chromatography. A (2012), 1256

In the context of green analytical chemistry, a supercritical fluid chromatography method was developed. In order to prove the potential of this technology, a worst case was selected, i.e. the separation ... [more ▼]

In the context of green analytical chemistry, a supercritical fluid chromatography method was developed. In order to prove the potential of this technology, a worst case was selected, i.e. the separation of very polar compounds. For that purpose, an innovative methodology based on design of experiments (DoE) and design space (DS) was previously developed and successfully tested on liquid chromatography. For the first time, this methodology was applied to a supercritical fluid chromatography (SFC) separation. First, a screening design was used to select the stationary phase and the nature of the mobile phase based on a maximization of the number of peaks eluted and a minimization of the number of co-eluted peaks. Then, a central composite design with orthogonal blocks defined a set of experiments used to model the retention times of each peak at the beginning, the apex, and the end. The gradient slope, the isocratic plateau before the gradient, the temperature, and the concentration of trifluoroacetic acid (TFA) in the mobile phase were the potentially influential factors. The critical quality attributes (CQAs), i.e. the separation (S) between peaks of the most critical pair, and the analysis time were the responses considered to assess the quality of the separation. The DS was computed as the multidimensional subspace where the probability for the separation and analysis time criteria to be within acceptance limits was higher than a defined quality level. The DS was computed propagating the prediction error from the modeled responses to the quality criterion using Monte Carlo simulations. The optimal condition was predicted at a gradient slope of 3.8% min−1 to linearly modify the modifier proportion between 5 and 40%, an isocratic time of 3 minutes, a concentration of TFA of 25 mM, and a temperature of 60.5 °C. This optimal condition was experimentally tested to confirm the prediction. Furthermore, chromatographic conditions included in the DS and on the limits of the DS were experimentally tested to assess the robustness of the developed SFC method. [less ▲]

Detailed reference viewed: 42 (13 ULg)